HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Boris Hadaschik Selected Research

abiraterone

8/2023Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer.
10/2021Mechanisms and markers of resistance to androgen signaling inhibitors in patients with metastatic castration-resistant prostate cancer.
1/2021Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer.
8/2017Therapy assessment in prostate cancer using choline and PSMA PET/CT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Boris Hadaschik Research Topics

Disease

105Prostatic Neoplasms (Prostate Cancer)
05/2024 - 06/2007
53Neoplasms (Cancer)
04/2024 - 04/2003
19Neoplasm Metastasis (Metastasis)
12/2023 - 10/2016
13Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2011
12Urinary Bladder Neoplasms (Bladder Cancer)
03/2024 - 01/2011
9Carcinoma (Carcinomatosis)
11/2023 - 04/2008
3Adenocarcinoma
01/2023 - 01/2018
3Margins of Excision
10/2020 - 01/2011
2Breast Neoplasms (Breast Cancer)
02/2024 - 01/2010
2Fatigue
01/2022 - 05/2016
2Residual Neoplasm
06/2017 - 06/2009
2Kidney Neoplasms (Kidney Cancer)
06/2015 - 04/2013
1Urologic Neoplasms (Urological Cancer)
03/2024
1Colorectal Neoplasms (Colorectal Cancer)
02/2024
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2024
1Lymphoma (Lymphomas)
02/2024
1Urinary Incontinence
09/2023
1Erectile Dysfunction
09/2023
1Sarcoma (Soft Tissue Sarcoma)
01/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2023
1Urachal adenocarcinoma
01/2023
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2022
1Thyroid Neoplasms (Thyroid Cancer)
10/2022
1COVID-19
02/2022
1Lymphocele
01/2022
1Non-Muscle Invasive Bladder Neoplasms
01/2022

Drug/Important Bio-Agent (IBA)

28AntigensIBA
04/2024 - 04/2012
15LigandsIBA
09/2023 - 10/2013
12Prostate-Specific Antigen (Semenogelase)IBA
05/2024 - 02/2012
11gallium 68 PSMA-11IBA
12/2023 - 10/2013
9Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2017
8Proteins (Proteins, Gene)FDA Link
02/2024 - 06/2007
8enzalutamideIBA
10/2022 - 01/2017
7Docetaxel (Taxotere)FDA Link
04/2024 - 12/2015
7AndrogensIBA
01/2023 - 11/2018
6PlatinumIBA
09/2023 - 01/2017
5ProBaseIBA
05/2024 - 08/2018
5Androgen Receptors (Androgen Receptor)IBA
04/2024 - 10/2014
5apalutamideIBA
12/2023 - 06/2021
5Hormones (Hormone)IBA
01/2023 - 06/2007
4ProteomeIBA
08/2023 - 02/2015
4abirateroneIBA
08/2023 - 08/2017
4ParaffinIBA
12/2020 - 11/2019
3cabazitaxelFDA Link
04/2024 - 01/2017
3Cisplatin (Platino)FDA LinkGeneric
03/2024 - 11/2019
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2024 - 01/2023
3Immune Checkpoint InhibitorsIBA
10/2023 - 05/2021
3HydrogelsIBA
01/2023 - 12/2012
3N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
01/2022 - 01/2017
3Messenger RNA (mRNA)IBA
01/2022 - 04/2003
3Formaldehyde (Formol)FDA Link
12/2020 - 01/2020
3Syndecan-1 (Syndecan 1)IBA
10/2020 - 01/2018
2RadiopharmaceuticalsIBA
05/2024 - 04/2024
2Lutetium-177IBA
04/2024 - 01/2021
268Ga-FAPIIBA
02/2024 - 01/2023
2RNA (Ribonucleic Acid)IBA
01/2024 - 10/2023
2Hemoglobins (Hemoglobin)IBA
10/2023 - 01/2022
2Poly(ADP-ribose) Polymerase InhibitorsIBA
09/2023 - 05/2021
2Abiraterone AcetateIBA
01/2022 - 01/2017
2Phenobarbital (Luminal)FDA Link
01/2022 - 07/2021
2Choline (Choline Chloride)IBA
10/2021 - 08/2017
2Protons (Proton)IBA
05/2016 - 03/2014
2CarbonIBA
05/2016 - 03/2014
2IonsIBA
05/2016 - 03/2014
2ClusterinIBA
01/2010 - 06/2007
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
04/2024
1pembrolizumabIBA
04/2024
1enfortumab vedotinIBA
04/2024
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2024
1Small Cytoplasmic RNAIBA
01/2024
1EP2 Subtype Prostaglandin E ReceptorsIBA
01/2024
1Dihydrotachysterol (AT 10)IBA
12/2023
1durvalumabIBA
11/2023
1LutetiumIBA
10/2023
1ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
01/2023
1PSMA-11IBA
01/2023
1Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA
10/2022
1Immune Checkpoint ProteinsIBA
10/2022
1IodineIBA
10/2022
1SolutionsIBA
08/2022
1Prednisolone (Predate)FDA LinkGeneric
01/2022
1CollagenIBA
01/2022
1Keratins (Keratin)IBA
01/2022
1darolutamideIBA
06/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2021
1olaparibIBA
05/2021
1rucaparibIBA
05/2021

Therapy/Procedure

55Therapeutics
05/2024 - 06/2009
41Castration
05/2024 - 04/2012
14Drug Therapy (Chemotherapy)
04/2024 - 06/2007
14Prostatectomy (Retropubic Prostatectomy)
09/2023 - 06/2009
10Radiotherapy
04/2024 - 04/2008
5Cystectomy
03/2024 - 01/2011
4Immunotherapy
03/2024 - 04/2012
4Lymph Node Excision (Lymph Node Dissection)
03/2024 - 01/2017
3Precision Medicine
01/2023 - 12/2021
2Proton Therapy
01/2023 - 04/2022
1Hematopoietic Stem Cell Mobilization
01/2024
1Cryosurgery
12/2023
1Adjuvant Chemotherapy
01/2023